Inventor · disambiguated record
Lewis Gazzard
Also filed as: GAZZARD LEWIS · GAZZARD LEWIS J · GAZZARD LEWIS JOHN
39 granted patents·23 pending applications·303 citations·filing 2001–2024
97Inventor score
Top patents by PatentIndex Score
62 records- 0198US7244851B2Inhibitors of IAPGENENTECH INC·Filed 2005·Granted Jul 17, 2007·141 cites·21 claims
- 0295US11566003B2Isoquinolines as inhibitors of HPK1GENENTECH INC·Filed 2020·Granted Jan 31, 2023·4 cites·31 claims
- 0395US9440976B21,7-diazacarbazoles and methods of useGENENTECH INC·Filed 2015·Granted Sep 13, 2016·10 cites·5 claims
- 0495US7947839B2Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of useGENENTECH INC·Filed 2006·Granted May 24, 2011·53 cites·16 claims
- 0594US11242344B2(4-hydroxypyrrolidin-2-yl)-heterocyclic compounds and methods of use thereofGENENTECH INC·Filed 2020·Granted Feb 8, 2022·5 cites·29 claims
- 0690US10407424B2Naphthyridines as inhibitors of HPK1GENENTECH INC·Filed 2018·Granted Sep 10, 2019·5 cites·72 claims
- 0789US11096982B2Inhibitors of IAPGENENTECH INC·Filed 2019·Granted Aug 24, 2021·2 cites·30 claims
- 0886US8716236B2Inhibitors of IAPGENENTECH INC·Filed 2013·Granted May 6, 2014·5 cites·8 claims
- 0985US9763942B2Serine/threonine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Sep 19, 2017·5 cites·18 claims
- 1085US9586991B2Inhibitors of IAPGENENTECH INC·Filed 2015·Granted Mar 7, 2017·3 cites·10 claims
- 1185US8110568B2Inhibitors of IAPCOHEN FREDERICK·Filed 2010·Granted Feb 7, 2012·7 cites·4 claims
- 1283US9238675B2Inhibitors of IAPGENENTECH INC·Filed 2014·Granted Jan 19, 2016·3 cites·18 claims
- 1382US10154995B2Serine/threonine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Dec 18, 2018·3 cites·18 claims
- 1482US8623889B2Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereofLYSSIKATOS JOSEPH P·Filed 2011·Granted Jan 7, 2014·7 cites·24 claims
- 1581US11034692B1Naphthyridines as inhibitors of HPK1GENENTECH INC·Filed 2019·Granted Jun 15, 2021·1 cites·20 claims
- 1681US9670208B2Serine/threonine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Jun 6, 2017·4 cites·19 claims
- 1780US11612606B28-aminoisoquinoline compounds and uses thereofGENENTECH INC·Filed 2019·Granted Mar 28, 2023·2 cites·29 claims
- 1880US10800780B2TDO2 InhibitorsGENENTECH INC·Filed 2016·Granted Oct 13, 2020·4 cites·17 claims
- 1980US9388171B2Serine/threonine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted Jul 12, 2016·6 cites·2 claims
- 2080US9187462B2Substituted quinazolines as serine/threonine kinase inhibitorsBLAKE JAMES F·Filed 2012·Granted Nov 17, 2015·6 cites·21 claims
- 2180US8501765B2Diazacarbazoles and methods of useCHEN HUIFEN·Filed 2009·Granted Aug 6, 2013·4 cites·37 claims
- 2280US8410279B2Substituted pyrroles and methods of useGAZZARD LEWIS J·Filed 2009·Granted Apr 2, 2013·7 cites·11 claims
- 2379US12338256B2Aza-tetracyclic oxazepine compounds and uses thereofGENENTECH INC·Filed 2024·Granted Jun 24, 2025·0 cites·28 claims
- 2479US11963994B2Inhibitors of IAPGENENTECH INC·Filed 2021·Granted Apr 23, 2024·0 cites·10 claims
- 2578US8247557B2IAP inhibitorsKOEHLER MICHAEL F T·Filed 2006·Granted Aug 21, 2012·4 cites·17 claims
- 2677US10766903B2Piperidine derivatives as inhibitors of ubiquitin specific protease 7ALMAC DISCOVERY LTD·Filed 2017·Granted Sep 8, 2020·3 cites·22 claims
- 2776US11603373B2TDO2 and IDO1 inhibitorsGENENTECH INC·Filed 2018·Granted Mar 14, 2023·2 cites·17 claims
- 2876US8980837B2Inhibitors of IAPCOHEN FREDERICK·Filed 2012·Granted Mar 17, 2015·2 cites·16 claims
- 2975US2024368170A1Cinnoline compounds and uses thereofGENENTECH INC·Filed 2024·Application pending·0 cites
- 3074US2025084096A1Tert-butyl (s)-2-(4-(phenyl)-6h-thieno[3, 2-f][1, 2, 4]triazolo[4, 3-a] [1,4]diazepin-6-yl) acetate derivatives and related compounds as bromodomain brd4 inhibitors for treating cancerGENENTECH INC·Filed 2024·Application pending·0 cites
- 3172US11827639B2TDO2 and IDO1 inhibitorsGENENTECH INC·Filed 2018·Granted Nov 28, 2023·1 cites·14 claims
- 3272US2024025919A1Aza-tetracyclic oxazepine compounds and uses thereofGENENTECH INC·Filed 2023·Application pending·0 cites
- 3372US2025042919A1Tetracyclic oxazepine compounds and uses thereofGENENTECH INC·Filed 2024·Application pending·0 cites
- 3471US8907092B2Inhibitors of IAPFLYGARE JOHN A·Filed 2008·Granted Dec 9, 2014·3 cites·12 claims
- 3570US2024132507A1TDO2 and IDO1 InhibitorsGENENTECH INC·Filed 2023·Application pending·0 cites
- 3667US10952995B2Azaindoles as inhibitors of HPK1GENENTECH INC·Filed 2019·Granted Mar 23, 2021·0 cites·32 claims
- 3766US2014171407A11,7-diazacarbazoles and methods of useGENENTECH INC·Filed 2014·Application pending·0 cites
- 3864US11944606B2Azaindoles as inhibitors of HPK1GENENTECH INC·Filed 2021·Granted Apr 2, 2024·0 cites·20 claims
- 3963US12152040B2Tert-butyl (s)-2-(4-(phenyl)-6H-thieno[3, 2-f][1, 2, 4]triazolo[4, 3-a] [1,4]diazepin-6-yl) acetate derivatives and related compounds as bromodomain BRD4 inhibitors for treating cancerGENENTECH INC·Filed 2021·Granted Nov 26, 2024·0 cites·31 claims
- 4062US2011124654A1Diazacarbazoles and methods of useCHEN HUIFEN·Filed 2009·Application pending·0 cites
- 4162US2022073520A1Cinnoline compounds and uses thereofGENENTECH INC·Filed 2021·Application pending·0 cites
- 4262US2022281893A1Tetracyclic oxazepine compounds and uses thereofGENENTECH INC·Filed 2022·Application pending·0 cites
- 4361US2017136084A1Inhibitors of iapGENENTECH INC·Filed 2017·Application pending·0 cites
- 4461US2007299052A1Inhibitors of IAPGENENTECH INC·Filed 2007·Application pending·0 cites
- 4560US7250447B2Acylsulfamide inhibitors of factor VIIaGENENTECH INC·Filed 2004·Granted Jul 31, 2007·1 cites·18 claims
- 4658US9216980B2Methods of use of diazacarbazoles for treating cancerGENENTECH INC·Filed 2014·Granted Dec 22, 2015·0 cites·37 claims
- 4758US2011183938A11,7-diazacarbazoles and methods of useGENENTECH INC·Filed 2010·Application pending·0 cites
- 4856US9206175B2Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereofGENENTECH INC·Filed 2013·Granted Dec 8, 2015·0 cites·22 claims
- 4955US2013261104A1Methods of use of diazacarbazoles for treating cancerGENENTECH INC·Filed 2013·Application pending·0 cites
- 5054US2018282282A1Isoquinolines as inhibitors of hpk1GENENTECH INC·Filed 2018·Application pending·0 cites
Showing the top 50 of 62 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Lewis Gazzard files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →